Isoginkgetin, a Potential CDK6 Inhibitor, Suppresses SLC2A1/GLUT1 Enhancer Activity to Induce AMPK-ULK1-Mediated Cytotoxic Autophagy in Hepatocellular Carcinoma

Investigators revealed that isoginkgetin (ISO) effectively inhibited HCC proliferation and migration in vitro. LC3-II expression and autophagosomes were increased under ISO treatment.